Variable | Total (n = 48) | FEVR diagnosed pre-operatively (n = 23) | FEVR diagnosed intra−/post-operatively (n = 25) | P value |
---|---|---|---|---|
Age at initial clinic visit (years) | 14.22 ± 13.87 | 15.65 ± 10.17 | 12.90 ± 16.68 | 0.499* |
Age range (years), (median) | 0.25–58 (12) | 0.25–41 (14) | 0.25–58 (6) | |
Sex | ||||
Female | 13 (27.1) | 4 (17.4) | 9 (36.0) | 0.147# |
Male | 35 (72.9) | 19 (82.6) | 16 (64.0) | |
Clinical stage of patients at initial presentation, n (%) # | ||||
Stage 2 | 2 (4.2) | 0 (0.0) | 2 (8.0) | 0.398^ |
Stage 3 | 11 (22.9) | 7 (30.4) | 4 (16.0) | |
Stage 4 | 12 (25.0) | 7 (30.4) | 5 (20.0) | |
Stage 5 | 23 (47.9) | 9 (39.1) | 14 (56.0) | |
Clinical stage in contralateral eye, n (%) | ||||
NON-FEVR | 1 (2.1) | 0 (0.0) | 1 (4.0) | 0.216^ |
Stage 1 | 22 (45.8) | 10 (43.5) | 12 (48.0) | |
Stage 2 | 17 (35.4) | 7 (30.4) | 10 (40.0) | |
Stage 3 | 5 (10.4) | 3 (13.0) | 2 (8.0) | |
Stage 4 | 1 (2.1) | 1 (4.4) | 0 (0.0) | |
Stage 5 | 2 (4.2) | 2 (8.7) | 0 (0.0) | |
Patient FA | ||||
+ | 35 (72.9) | 15 (65.2) | 20 (80.0) | – |
N/A | 13 (27.1) | 8 (34.8) | 5 (20.0) | |
Referral diagnosis/pre-operative diagnosis, n (%) | ||||
Unilateral RD | 25 (52.1) | 14 (60.9) | 11 (44.0) | – |
Bilateral RD | 4 (8.3) | 3 (13.0) | 1 (4.0) | |
Bilateral PFV | 2 (4.2) | 2 (8.7) | 0 (0.0) | |
Unilateral PFV | 4 (8.3) | 1 (4.3) | 3 (12.0) | |
Ocular trauma | 1 (2.1) | 1 (4.3) | 0 (0.0) | |
Bilateral FEVR | 2 (4.2) | 2 (8.7) | 0 (0.0) | |
Unilateral PFV + ROP | 1 (2.1) | 0 (0.0) | 1 (4.0) | |
Unilateral RB | 2 (4.2) | 0 (0.0) | 2 (8.0) | |
Unilateral congenital cataract + VH + RD | 1 (2.1) | 0 (0.0) | 1 (4.0) | |
Unilateral RD + VH | 1 (2.1) | 0 (0.0) | 1 (4.0) | |
VH + contralateral ERM | 1 (2.1) | 0 (0.0) | 1 (4.0) | |
Unilateral VH + aphakia | 1 (2.1) | 0 (0.0) | 1 (4.0) | |
Bilateral MF + LMH + HM | 1 (2.1) | 0 (0.0) | 1 (4.0) | |
Bilateral congenital cataract+ unilateral PFV | 1 (2.1) | 0 (0.0) | 1 (4.0) | |
Unilateral ERM | 1 (2.1) | 0 (0.0) | 1 (4.0) |